Blue Crest Capital Management LTD Bristol Myers Squibb CO Put Options Transaction History

Blue Crest Capital Management LTD

  • $1.71 Billion
  • Q2 2024

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

May 15, 2024
SELL
$47.98 - $54.4 $2.31 Million - $2.62 Million
-48,200 Reduced 51.72%
45,000 $2.44 Million
Q4 2023

Feb 14, 2024
BUY
$48.48 - $57.85 $2.73 Million - $3.26 Million
56,400 Added 153.26%
93,200 $4.78 Million
Q3 2023

Nov 14, 2023
BUY
$57.89 - $64.73 $2.13 Million - $2.38 Million
36,800 New
36,800 $2.14 Million

Others Institutions Holding BMY

# of Institutions
2,428
Shares Held
1.5B
Call Options Held
29.7M
Put Options Held
32.2M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Blue Crest Capital Management LTD Portfolio

Follow Blue Crest Capital Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blue Crest Capital Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Blue Crest Capital Management LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email